InvestSMART

Vitura Health Limited (ASX: VIT) - Announcements

- Current share price for VIT : $0.020

ASX company news and announcements for Vitura Health Limited (VIT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Vitura Health Limited (VIT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Vitura Health Limited (VIT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Vitura Health Limited (VIT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Change in substantial holding from BTT 8 Jun 2016 4:34PM $1.685 $0.020 fallen by 98.81%
$13 Becoming a substantial holder from CBA 7 Jun 2016 5:04PM $1.730 $0.020 fallen by 98.84%
$13 Ceasing to be a substantial holder from CBA 2 Jun 2016 4:53PM $1.695 $0.020 fallen by 98.82%
$13 Becoming a substantial holder from CBA 24 May 2016 2:15PM $1.790 $0.020 fallen by 98.88%
$13 Ceasing to be a substantial holder from CBA 23 May 2016 3:48PM $1.855 $0.020 fallen by 98.92%
$13 Ceasing to be a substantial holder from IFL 16 May 2016 4:50PM $1.925 $0.020 fallen by 98.96%
$13 Becoming a substantial holder from CBA 4 May 2016 5:26PM $1.650 $0.020 fallen by 98.79%
$13 Ceasing to be a substantial holder from CBA 3 May 2016 4:07PM $1.780 $0.020 fallen by 98.88%
$13 Vitaco Presentation to the Select Equities Conference 020516 3 May 2016 8:48AM $1.810 $0.020 fallen by 98.90%
$13 Operational Update 29 Apr 2016 8:58AM $1.500 $0.020 fallen by 98.67%
$13 Becoming a substantial holder from CBA 28 Apr 2016 2:59PM $1.490 $0.020 fallen by 98.66%
$13 Becoming a substantial holder from IFL 27 Apr 2016 4:29PM $1.465 $0.020 fallen by 98.63%
$13 Vitaco Response to Chinese Regulatory Change 13 Apr 2016 9:11AM $1.500 $0.020 fallen by 98.67%
$13 S&P DJ Indices Announces March Quarterly Review 11 Mar 2016 8:25AM $1.810 $0.020 fallen by 98.90%
$13 Investor Presentation 1H16 Half-Year Financial Results 24 Feb 2016 8:22AM $2.270 $0.020 fallen by 99.12%
$13 Vitaco First Half FY16 Result 24 Feb 2016 8:21AM $2.270 $0.020 fallen by 99.12%
$13 Dividend/Distribution - VIT 24 Feb 2016 8:20AM $2.270 $0.020 fallen by 99.12%
$13 Appendix 4D - Half Yearly Report and Accounts 24 Feb 2016 8:19AM $2.270 $0.020 fallen by 99.12%
$13 Half Year Earnings Release Date 18 Feb 2016 1:44PM $2.260 $0.020 fallen by 99.12%
$13 Change in substantial holding from BTT 12 Feb 2016 4:38PM $2.050 $0.020 fallen by 99.02%
$13 Vitaco update to the market 9 Feb 2016 3:18PM $2.000 $0.020 fallen by 99%
$13 Ceasing to be a substantial holder 6 Nov 2015 5:14PM $2.980 $0.020 fallen by 99.33%
$13 Company Secretary Appointment/Resignation 21 Oct 2015 5:42PM $2.780 $0.020 fallen by 99.28%
$13 Resolution of dispute with Healthzone 13 Oct 2015 4:50PM $2.640 $0.020 fallen by 99.24%
$13 Ceasing to be a substantial holder from AMP 25 Sep 2015 3:11PM $2.740 $0.020 fallen by 99.27%

276 - 300 of 343 results

Page 12 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.